SERINC5-mediated enhancement of patient-derived envelopes sensitivity to neutralization by bNAbs and autologous plasma antibodies

3BNC117 - Rockefeller University, Cornell University, Frontier Biotech, Gilead

VRC01 - Acuitas Therap

E. Nkuwi1,2; G. Barabona3,2; M. Toyoda2; B. Sunguya4,5; D. Kamori3,5; T. Ueno3,2

Aug 9, 2024